On the other hand, LMWHs
, such as enoxaparin have been shown to be as safe and effective as intravenous UFH [20, 21].
were also administered into her abdominal region.
(2) It brings forth an important aspect in healthcare delivery, where the patient refuses the use of low molecular weight heparin (LMWH
) in view of its being an animal origin, despite the fact that the patient was in very much need of deep vein thrombosis prophylaxis.
is strongly recommended for intervention in the prevention and management of thromboembolism complications [21-23].
There is increasing use of low-molecular-weight heparin (LMWH
) for treatment of pediatric thromboembolic disease as it has been shown to be safe and effective.
developed an interesting system which comprises two anticancer drugs, ATRA (all trans retinoic acid) and DOX (doxorubicin), the first one being conjugated to LMWH
(low molecular weight heparin) and the second one loaded physically, such system was named as DOX-loaded LMWH-ATRA.
Although naturally and physiologically involved in the clotting process, increased levels of thrombin are associated with pathological states and can be controlled by the anti-Xa activity of pharmacological agents such as heparin and LMWH
, which are historically delivered subcutaneously.
Compare and contrast the pharmacokinetics of different low molecular weight heparins (LMWH
Stable patients should receive antiplatelet therapy and anticoagulation with unfractionated heparins or LMWHs
Low risk group and high risk group with negative colour Doppler were given low molecular weight heparin (LMWH
) from the day of admission.
In the majority of cases, LMWH
is the preferred agent for both the initial and prolonged treatment phase assuming adequate renal function.
We think that both LMWHs
have the group effect property.